‘Implications’ for rollout as second clotting reaction announced

The TGA has announced a second case of thrombosis with thrombocytopenia likely to be associated with the AstraZeneca COVID-19 vaccine It issued a statement saying that the Vaccine Safety Investigation Group, its panel of expert advisors, met on Monday evening, where it concluded that a recently reported case of thrombosis with thrombocytopenia is likely to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The APP in one minute
Next Designer drug deaths prompt urgent call